Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: Evidence for the nonestrogenic osteogenic effect of the standardized fraction

Menopause

Volumn 17, Issue 3, 2010, Pages 602-610

  Pandey, Rashmi ^a   Gautam, Abnish K ^a   Bhargavan, Biju ^a   Trivedi, Ritu ^a   Swarnkar, Gaurav ^a   Nagar, Geet K ^a   Yadav, Dinesh K ^a   Kumar, Manmeet ^a   Rawat, Preeti ^a   Manickavasagam, Lakshmi ^a   Kumar, Amit ^a   Maurya, Rakesh ^a   Goel, Atul ^a   Jain, Girish K ^a   Chattopadhyay, Naibedya ^a   Singh, Divya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Bone formation rate; Bone remodeling; Estrogenicity; Osteogenic; Ovariectomy

Indexed keywords

BUTEA MONOSPERMA EXTRACT; COLLAGEN TYPE 1; OSTEOCALCIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; BONE DENSITY; BONE TURNOVER; BUTEA; BUTEA MONOSPERMA; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; TRABECULAR BONE;

ANIMALS; BONE DENSITY; BUTEA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISOFLAVONES; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77952275063     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d0f7f0     Document Type: Article

References (18)

1. Cassidy A. Dietary phytoestrogens and bone health. J Br Menopause Soc 2003;9:17-21.
2. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors > and A. J Cell Biochem 2003;89:633-646.
3. Chiechi LM. Dietary phytoestrogens in the prevention of long-term postmenopausal diseases. Int J Gynaecol Obstet 1999;67:39-40.
4. Ishimi Y. Soybean isoflavones in bone health. Forum Nutr 2009;61: 104-116.
5. Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998;12:543-557.
6. Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001;285:1482-1488.
7. Maurya R, Yadav DK, Singh G, et al. Osteogenic activity of constituents from Butea monosperma. Bioorg Med Chem Lett 2009;19:610-613.
8. Bhargavan B, Gautam AK, Singh D, et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem 2009;388-399.
9. Trivedi R, Kumar S, Kumar A, et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 2008;289:85-93.
10. Hara K, Kobayashi M, Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 2002;31:575-581.
11. Trivedi R, Kumar A, Gupta V, et al. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol Cell Endocrinol 2009;302:86-91.
12. Hildebrand T, Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng 1997;1:15-23.
13. Sharan K, Siddiqui JA, Swarnkar G, et al. Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect. Menopause 2009; doi:10.1097/gme.0b013e3181bfae38.
14. Ghosh R, Kamboj VP, Singh MM. Interaction with anti-implantation and estrogen antagonistic activities of DL-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats. Contraception 2001;64:261-269.
15. Rawat P, Kumar M, Sharan K, Chattopadhyay N, Maurya R. Ulmosides A and B. Flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase. Bioorg Med Chem Lett. 2009;19:4684-4687.
16. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-661.
17. MacGregor JI, Jordan VC. Basic guide to the mechanisms of anti-estrogen action. Pharmacol Rev 1998;50:151-196.
18. Neves ECM. Association of ovarian and uterine cancers with postmeno-pausal hormonal treatments. Clin Obstet Gynecol 2008;51:607-617.